Vanda Pharmaceuticals reported $6.32M in Cost of Sales for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US USD 2.14M 531K
Acorda Therapeutics ACOR:US USD 11M 2.2M
Agios Pharmaceuticals AGIO:US USD 517K 82K
Akebia Therapeutics AKBA:US USD 29.68M 19.2M
Alnylam Pharmaceuticals ALNY:US USD 41.12M 308K
Anika Therapeutics ANIK:US USD 17.48M 2.69M
AstraZeneca AZN:LN USD 2.12B 214M
Bristol Myers Squibb BMY:US USD 2.35B 324M
Clovis Oncology CLVS:US USD 8.61M 607K
Eli Lilly And LLY:US USD 1.58B 148.6M
Esperion Therapeutics ESPR:US USD 6.51M 2.67M
Halozyme Therapeutics HALO:US USD 47.32M 13.38M
Heron Therapeutics HRTX:US USD 14.72M 1.46M
Insmed INSM:US USD 13.47M 2.92M
Intercept Pharmaceuticals ICPT:US USD 424K 115K
Johnson & Johnson JNJ:US USD 7.81B 95M
Ligand Pharmaceuticals LGND:US USD 14.15M 1.79M
Merk MRK:US USD 3.43B 715M
Moderna Inc MRNA:US USD 1.1B 281M
Novartis NVS:US USD 3.66B 92M
Pfizer PFE:US USD 6.09B 2.58B
Ptc Therapeutics PTCT:US USD 14.01M 4.37M
Puma Biotechnology PBYI:US USD 12.5M 2.42M
Takeda 4502:JP JPY 305.44B 12.56B
Teva Pharmaceutical TEVA:IT USD 1.88B 73M
Ultragenyx Pharmaceutical RARE:US USD 8.63M 361K
Vanda Pharmaceuticals VNDA:US USD 6.32M 261K
Veracyte VCYT:US USD 26.01M 978K